APA (7th ed.) Citation

RJ, B., V, H., K, S., J, P., S, D., S, P., . . . MP, F. (2015). Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: A randomized first-line phase II trial. Clinical genitourinary cancer, 13(1), 50. https://doi.org/10.1016/j.clgc.2014.07.002

Chicago Style (17th ed.) Citation

RJ, Broom, et al. "Everolimus and Zoledronic Acid in Patients with Renal Cell Carcinoma with Bone Metastases: A Randomized First-line Phase II Trial." Clinical Genitourinary Cancer 13, no. 1 (2015): 50. https://doi.org/10.1016/j.clgc.2014.07.002.

MLA (9th ed.) Citation

RJ, Broom, et al. "Everolimus and Zoledronic Acid in Patients with Renal Cell Carcinoma with Bone Metastases: A Randomized First-line Phase II Trial." Clinical Genitourinary Cancer, vol. 13, no. 1, 2015, p. 50, https://doi.org/10.1016/j.clgc.2014.07.002.